Manufacturing of a Dissolving Microneedle Patch to Administer Rotavirus Vaccine
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Centers for Disease Control and Prevention (CDC) intends to award a Firm Fixed-Price sole source contract to Micron Biomedical Incorporated for the manufacturing of a dissolving microneedle patch to administer rotavirus vaccine. This is a Notice of Intent to Award a Sole Source Contract and not a request for competitive quotes. Interested sources must submit capability statements to demonstrate their ability to meet the requirement.
Scope of Work
The requirement is to manufacture a microneedle (MN) patch designed to deliver a live attenuated rotavirus vaccine. This patch is intended for use in a planned clinical trial in the future.
Contract & Timeline
- Type: Firm Fixed-Price (Sole Source Intent)
- Period of Performance: April 15, 2026, through April 14, 2028
- Anticipated Award Date: On or before April 24, 2026
- NAICS Code: 541715 (Research and Development In The Physical, Engineering And Life Sciences)
- Set-Aside: None specified
- Capability Statements Due: April 8, 2026, by 10:00 AM Eastern Standard Time (EST)
- Published: March 24, 2026
Evaluation
This notice is not a request for competitive proposals. The Government intends to proceed with a sole source award based on the determination that only one responsible source can satisfy agency requirements (FAR 13.106-1(b)(1)(i) and 10 U.S.C. 2304(c)(1)). Capability statements received will be considered solely to determine if a competitive procurement is feasible or if the sole source contract should proceed.
Additional Notes
Capability statements must include management, technical, and cost information, clearly demonstrating the ability to provide the requested services. Statements shall not exceed 2 (8.5 x 11 inch) pages, using a font size no smaller than 10-point. Submissions must be sent by email ONLY as a Microsoft Word or Adobe PDF attachment to Tim Williams at TPW8@cdc.gov. Telephone requests or offers will not be honored.